1. Home
  2. TRIB vs AIDX Comparison

TRIB vs AIDX Comparison

Compare TRIB & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Biotech plc

TRIB

Trinity Biotech plc

HOLD

Current Price

$12.45

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.46

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIB
AIDX
Founded
1992
N/A
Country
Ireland
United States
Employees
N/A
14
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.7M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TRIB
AIDX
Price
$12.45
$0.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
724.2K
213.0K
Earning Date
05-22-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.51
N/A
Revenue Next Year
$13.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.45
52 Week High
$9.85
$14.09

Technical Indicators

Market Signals
Indicator
TRIB
AIDX
Relative Strength Index (RSI) 98.39 31.67
Support Level $0.64 N/A
Resistance Level N/A $0.70
Average True Range (ATR) 0.53 0.04
MACD 1.23 0.01
Stochastic Oscillator 95.82 17.79

Price Performance

Historical Comparison
TRIB
AIDX

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: